Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.

PubWeight™: 1.92‹?› | Rank: Top 3%

🔗 View Article (PMID 32061335)

Published in Lancet Respir Med on February 13, 2020

Authors

Jinnong Zhang1, Luqian Zhou2, Yuqiong Yang3, Wei Peng4, Wenjing Wang5, Xuelin Chen6

Author Affiliations

1: Department of Emergency Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: zhangjnwhhb@163.com.
2: First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China. Electronic address: zhlx09@163.com.
3: First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, Guangzhou, China.
4: Division of ICU and Respiratory Service, Department of Internal Medicine, Salt Lake Regional Medical Center, Heart and Lung Institute of Utah, Salt Lake City, UT, USA.
5: Department of Emergency Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
6: Department of Gerontology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Associated clinical trials:

BCG Vaccine for Health Care Workers as Defense Against COVID 19 (BADAS) | NCT04348370

Immunogenetics Predictors With COVID-19 | NCT04390269

BCG Vaccination to Prevent COVID-19 (NUEVA) | NCT04632537

Articles citing this

Adoption of COVID-19 triage strategies for low-income settings. Lancet Respir Med (2020) 1.38